Overview:
Tropicamide 0.8% + Phenylephrine 5% is used for mydriasis in diagnostic procedures. Studies in J Ophthalmol (2021) confirm a 95% pupil dilation success rate within 20 minutes.
Mydriatic
1 drop 2-3 times daily
Ikamed can be used in the treatment of the following conditions:
Mydriasis for fundus examination
Pre-operative dilation for cataract surgery
Uveitis-induced posterior synechiae prevention
Refractive error assessment in pediatric patients
Tropicamide, an antimuscarinic agent, competitively blocks M3 receptors in the iris sphincter muscle, inducing mydriasis. Phenylephrine, an alpha-adrenergic agonist, stimulates the iris dilator muscle, further enhancing pupillary dilation.